The National Healthcare and Security Administration officially ended its negotiations for the 2022 national healthcare list on Sunday. Three anti-COVID-19 drugs that were discussed include Azvudine developed by a domestic company; Qingfei Paidu granules, a widely used traditional Chinese medicine; and Paxlovid, developed by Pfizer.
TCM treatment s role detailed for nation s COVID-19 protocol--China Economic Net en.ce.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from en.ce.cn Daily Mail and Mail on Sunday newspapers.